Further Evidence that Immunotherapy Provides a Longterm Survival Benefit for Lung Cancer Patients – Drug Discovery & Development
Drug Discovery & Development |
Further Evidence that Immunotherapy Provides a Longterm Survival Benefit for Lung Cancer Patients
Drug Discovery & Development Further evidence that immunotherapy provides long-term survival benefit for patients with lung cancer was presented today at ELCC 2018 (European Lung Cancer Congress) in Geneva, Switzerland. Researchers presented the three-year survival results of the … Updated Atezolizumab Findings Confirm Long-Term Survival Exists in Lung Cancer, Expert Says Frontline Atezolizumab Combo Emerges as Potential New Standard in NSCLC |
